Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice

DMM Disease Models and Mechanisms

Volumn 4, Issue 3, 2011, Pages 347-358

  Derksen, Patrick W B ^a,b   Braumuller, Tanya M ^a   Van Der Burg, Eline ^a   Hornsveld, Marten ^a   Mesman, Elly ^a   Wesseling, Jelle ^a   Krimpenfort, Paul ^a   Jonkers, Jos ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOIKIS; APOPTOSIS; ARTICLE; BONE; BREAST CANCER; BREAST DEVELOPMENT; BREAST EPITHELIUM; CANCER INVASION; CELL ADHESION; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TRACT; INVASIVE LOBULAR CARCINOMA; LACTATION; LUNG; LYMPH NODE; MAMMARY GLAND FUNCTION; METASTASIS; MOUSE; NONHUMAN; PERITONEUM; PREGNANCY; PRIORITY JOURNAL; TISSUE SPECIFICITY;

ADENOCARCINOMA; ANIMALS; CADHERINS; CARCINOMA, LOBULAR; FEMALE; GENE SILENCING; HUMANS; INTEGRASES; LACTATION; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ORGAN SPECIFICITY; PRECANCEROUS CONDITIONS; PREGNANCY; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 79956108858     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.006395     Document Type: Article

References (70)

1. Alvarez, J. V., Perez, D. and Chodosh, L. A. (2006). MILC-ing the mouse mammary gland: A model for invasive lobular carcinoma. Cancer Cell 10, 347-349.
2. Arpino, G., Bardou, V. J., Clark, G. M. and Elledge, R. M. (2004). Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 6, R149-R156.
3. Batlle, E., Sancho, E., Franci, C., Dominguez, D., Monfar, M., Baulida, J. and Garcia De Herreros, A. (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2, 84-89.
4. Bentz, J. S., Yassa, N. and Clayton, F. (1998). Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod. Pathol. 11, 814-822. (Pubitemid 28440877)
5. Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C. and van Roy, F. (1995). E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 14, 6107-6115. (Pubitemid 26007298)
6. Boussadia, O., Kutsch, S., Hierholzer, A., Delmas, V. and Kemler, R. (2002). E-cadherin is a survival factor for the lactating mouse mammary gland. Mech. Dev. 115, 53-62. (Pubitemid 34615667)
7. Buchanan, C. L., Flynn, L. W., Murray, M. P., Darvishian, F., Cranor, M. L., Fey, J. V., King, T. A., Tan, L. K. and Sclafani, L. M. (2008). Is pleomorphic lobular carcinoma really a distinct clinical entity? J. Surg. Oncol. 98, 314-317.
8. Caligioni, C. S. (2009). Assessing reproductive status/stages in mice. Curr. Protoc. Neurosci. Appendix 4, Appendix 4I.
9. Cano, A., Perez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F. and Nieto, M. A. (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2, 76-83.
10. Clarke, D. L., Arey, B. J. and Linzer, D. I. (1993). Prolactin receptor messenger ribonucleic acid expression in the ovary during the rat estrous cycle. Endocrinology 133, 2594-2603. (Pubitemid 24000708)
11. Cleton-Jansen, A. M., Moerland, E. W., Kuipers-Dijkshoorn, N. J., Callen, D. F., Sutherland, G. R., Hansen, B., Devilee, P. and Cornelisse, C. J. (1994). At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer 9, 101-107. (Pubitemid 24047465)
12. Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D. and van Roy, F. (2001). The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 7, 1267-1278. (Pubitemid 32607360)
13. Coradini, D., Pellizzaro, C., Veneroni, S., Ventura, L. and Daidone, M. G. (2002). Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence. Br. J. Cancer 87, 1105-1111.
14. Dale, T. C., Krnacik, M. J., Schmidhauser, C., Yang, C. L., Bissell, M. J. and Rosen, J. M. (1992). High-level expression of the rat whey acidic protein gene is mediated by elements in the promoter and 3′ untranslated region. Mol. Cell Biol. 12, 905-914.
15. Derksen, P. W., de Gorter, D. J., Meijer, H. P., Bende, R. J., van Dijk, M., Lokhorst, H. M., Bloem, A. C., Spaargaren, M. and Pals, S. T. (2003). The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma. Leukemia 17, 764-774.
16. Derksen, P. W., Liu, X., Saridin, F., Van Der Gulden, H., Zevenhoven, J., Evers, B., van Beijnum, J. R., Griffioen, A. W., Vink, J., Krimpenfort, P. et al. (2006). Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10, 437-449. (Pubitemid 44693469)
17. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D. and Birchmeier, W. (1991). E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113, 173-185. (Pubitemid 21909684)
18. Frykberg, E. R., Santiago, F., Betsill, W. L., Jr and O'Brien, P. H. (1987). Lobular carcinoma in situ of the breast. Surg. Gynecol. Obstet. 164, 285-301.
19. Fujita, N., Jaye, D. L., Kajita, M., Geigerman, C., Moreno, C. S. and Wade, P. A. (2003). MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113, 207-219.
20. Gimeno, R., Weijer, K., Voordouw, A., Uittenbogaart, C. H., Legrand, N., Alves, N. L., Wijnands, E., Blom, B. and Spits, H. (2004). Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells. Blood 104, 3886-3893. (Pubitemid 39620134)
21. Gonzalez-Angulo, A. M., Morales-Vasquez, F. and Hortobagyi, G. N. (2007). Overview of resistance to systemic therapy in patients with breast cancer. Adv. Exp. Med. Biol. 608, 1-22.
22. Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E. and Baylin, S. B. (1995). E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55, 5195-5199.
23. Gudlaugsson, E., Skaland, I., Janssen, E. A., van Diest, P. J., Voorhorst, F. J., Kjellevold, K., Hausen, A. Z. and Baak, J. P. (2009). Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer. Breast Cancer Res. Treat. 121, 35-40.
24. Gump, F. E. (1993). Lobular carcinoma in situ (LCIS): pathology and treatment. J. Cell. Biochem. Suppl. 17, 53-58.
25. Helvie, M. A., Paramagul, C., Oberman, H. A. and Adler, D. D. (1993). Invasive lobular carcinoma. Imaging features and clinical detection. Invest. Radiol. 28, 202-207.
26. Hennighausen, L. G. and Sippel, A. E. (1982). Mouse whey acidic protein is a novel member of the family of 'four-disulfide core' proteins. Nucleic Acids Res. 10, 2677-2684.
27. Hulsken, J., Birchmeier, W. and Behrens, J. (1994). E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J. Cell Biol. 127, 2061-2069.
28. Jonkers, J., Meuwissen, R., Van Der Gulden, H., Peterse, H., van der Valk, M. and Berns, A. (2001). Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29, 418-425. (Pubitemid 34326692)
29. Kaya, H., Aribal, E. and Yegen, C. (2002). Apocrine differentiation in invasive pleomorphic lobular carcinoma with in situ ductal and lobular apocrine carcinoma: case report. Pathol. Oncol. Res. 8, 151-152. (Pubitemid 34988069)
30. Khanna, C. and Hunter, K. (2005). Modeling metastasis in vivo. Carcinogenesis 26, 513-523. (Pubitemid 41214139)
31. Korkola, J. E., DeVries, S., Fridlyand, J., Hwang, E. S., Estep, A. L., Chen, Y. Y., Chew, K. L., Dairkee, S. H., Jensen, R. M. and Waldman, F. M. (2003). Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res. 63, 7167-7175.
32. Krecke, K. N. and Gisvold, J. J. (1993). Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am. J. Roentgenol. 161, 957-960. (Pubitemid 23333151)
33. Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F., Csiszar, K., Giaccia, A., Weninger, W. et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906.
34. Liu, X., Holstege, H., van der Gulden, H., Treur-Mulder, M., Zevenhoven, J., Velds, A., Kerkhoven, R. M., van Vliet, M. H., Wessels, L. F., Peterse, J. L. et al. (2007). Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc. Natl. Acad. Sci. USA 104, 12111-12116. (Pubitemid 47185638)
35. Marchetti, A., Buttitta, F., Pellegrini, S., Campani, D., Diella, F., Cecchetti, D., Callahan, R. and Bistocchi, M. (1993). P53 mutations and histological type of invasive breast carcinoma. Cancer Res. 53, 4665-4669. (Pubitemid 23304397)
36. Mathieu, M. C., Rouzier, R., Llombart-Cussac, A., Sideris, L., Koscielny, S., Travagli, J. P., Contesso, G., Delaloge, S. and Spielmann, M. (2004). The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur. J. Cancer 40, 342-351. (Pubitemid 38121270)
37. Middleton, L. P., Palacios, D. M., Bryant, B. R., Krebs, P., Otis, C. N. and Merino, M. J. (2000). Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am. J. Surg. Pathol. 24, 1650-1656.
38. Mohsin, S. K., O'Connell, P., Allred, D. C. and Libby, A. L. (2005). Biomarker profile and genetic abnormalities in lobular carcinoma in situ. Breast Cancer Res. Treat. 90, 249-256.
39. Molland, J. G., Donnellan, M., Janu, N. C., Carmalt, H. L., Kennedy, C. W. and Gillett, D. J. (2004). Infiltrating lobular carcinoma-a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast 13, 389-396. (Pubitemid 39549788)
40. Moody, S. E., Perez, D., Pan, T. C., Sarkisian, C. J., Portocarrero, C. P., Sterner, C. J., Notorfrancesco, K. L., Cardiff, R. D. and Chodosh, L. A. (2005). The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8, 197-209.
41. Newstead, G. M., Baute, P. B. and Toth, H. K. (1992). Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology 184, 623-627.
42. Oda, T., Kanai, Y., Oyama, T., Yoshiura, K., Shimoyama, Y., Birchmeier, W., Sugimura, T. and Hirohashi, S. (1994). E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl. Acad. Sci. USA 91, 1858-1862. (Pubitemid 24080305)
43. Orvieto, E., Maiorano, E., Bottiglieri, L., Maisonneuve, P., Rotmensz, N., Galimberti, V., Luini, A., Brenelli, F., Gatti, G. and Viale, G. (2008). Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution. Cancer 113, 1511-1520.
44. Ottewell, P. D., Coleman, R. E. and Holen, I. (2006). From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies. Breast Cancer Res. Treat. 96, 101-113.
45. Perez-Moreno, M., Jamora, C. and Fuchs, E. (2003). Sticky business: orchestrating cellular signals at adherens junctions. Cell 112, 535-548. (Pubitemid 36263085)
46. Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H. and Christofori, G. (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190-193. (Pubitemid 28162793)
47. Pittius, C. W., Sankaran, L., Topper, Y. J. and Hennighausen, L. (1988). Comparison of the regulation of the whey acidic protein gene with that of a hybrid gene containing the whey acidic protein gene promoter in transgenic mice. Mol. Endocrinol. 2, 1027-1032. (Pubitemid 18262258)
48. Radice, G. L., Ferreira-Cornwell, M. C., Robinson, S. D., Rayburn, H., Chodosh, L. A., Takeichi, M. and Hynes, R. O. (1997). Precocious mammary gland development in P-cadherin-deficient mice. J. Cell Biol. 139, 1025-1032.
49. Reis-Filho, J. S., Simpson, P. T., Jones, C., Steele, D., Mackay, A., Iravani, M., Fenwick, K., Valgeirsson, H., Lambros, M., Ashworth, A. et al. (2005). Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J. Pathol. 207, 1-13. (Pubitemid 41200708)
50. Rosen, P. P., Kosloff, C., Lieberman, P. H., Adair, F. and Braun, D. W., Jr (1978). Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am. J. Surg. Pathol. 2, 225-251.
51. Rosen, P. P., Lesser, M. L., Arroyo, C. D., Cranor, M., Borgen, P. and Norton, L. (1995). P53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J. Clin. Oncol. 13, 821-830.
52. Savagner, P., Yamada, K. M. and Thiery, J. P. (1997). The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell Biol. 137, 1403-1419. (Pubitemid 27265951)
53. Simpson, P. T., Gale, T., Fulford, L. G., Reis-Filho, J. S. and Lakhani, S. R. (2003). The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res. 5, 258-262.
54. Simpson, P. T., Reis-Filho, J. S., Lambros, M. B., Jones, C., Steele, D., Mackay, A., Iravani, M., Fenwick, K., Dexter, T., Jones, A. et al. (2008). Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J. Pathol. 215, 231-244. (Pubitemid 351956704)
55. Sneige, N., Wang, J., Baker, B. A., Krishnamurthy, S. and Middleton, L. P. (2002). Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod. Pathol. 15, 1044-1050.
56. Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71.
57. Soslow, R. A., Carlson, D. L., Horenstein, M. G. and Osborne, M. P. (2000). A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas. Breast Cancer Res. Treat. 61, 161-170.
58. Stange, D. E., Radlwimmer, B., Schubert, F., Traub, F., Pich, A., Toedt, G., Mendrzyk, F., Lehmann, U., Eils, R., Kreipe, H. et al. (2006). High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Clin. Cancer Res. 12, 345-352. (Pubitemid 43166120)
59. Takeichi, M. (1995). Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 7, 619-627.
60. Topper, Y. J. and Freeman, C. S. (1980). Multiple hormone interactions in the developmental biology of the mammary gland. Physiol. Rev. 60, 1049-1106.
61. Tubiana-Hulin, M., Stevens, D., Lasry, S., Guinebretiere, J. M., Bouita, L., Cohen- Solal, C., Cherel, P. and Rouesse, J. (2006). Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Ann. Oncol. 17, 1228-1233. (Pubitemid 44288213)
62. Vleminckx, K., Vakaet, L., Jr, Mareel, M., Fiers, W. and van Roy, F. (1991). Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66, 107-119. (Pubitemid 121001351)
63. Vos, C. B., Cleton-Jansen, A. M., Berx, G., de Leeuw, W. J., ter Haar, N. T., van Roy, F., Cornelisse, C. J., Peterse, J. L. and van de Vijver, M. J. (1997). E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br. J. Cancer 76, 1131-1133.
64. Wagner, K. U., Wall, R. J., St Onge, L., Gruss, P., Wynshaw-Boris, A., Garrett, L., Li, M., Furth, P. A. and Hennighausen, L. (1997). Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25, 4323-4330. (Pubitemid 27485212)
65. Wheeler, J. E., Enterline, H. T., Roseman, J. M., Tomasulo, J. P., McIlvaine, C. H., Fitts, W. T., Jr and Kirshenbaum, J. (1974). Lobular carcinoma in situ of the breast. Long-term followup. Cancer 34, 554-563.
66. Whittingham, D. G. and Wood, M. J. (1983). The Mouse in Biomedical Research, Reproductive Physiology (Foster, H. L., Small, J. D. and Fox, J. G., eds), pp. 137-164. New York: Academic Press.
67. Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A. and Weinberg, R. A. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939.
68. Yoshidome, K., Shibata, M. A., Couldrey, C., Korach, K. S. and Green, J. E. (2000). Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression. Cancer Res. 60, 6901-6910.
69. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T. and Hirohashi, S. (1995). Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA 92, 7416-7419.
70. Zhao, H., Langerod, A., Ji, Y., Nowels, K. W., Nesland, J. M., Tibshirani, R., Bukholm, I. K., Karesen, R., Botstein, D., Borresen-Dale, A. L. et al. (2004). Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell 15, 2523-2536. (Pubitemid 38691844)